Virpax Pharmaceuticals' market value is the price at which a share of Virpax Pharmaceuticals trades on a public exchange. It measures the collective expectations of Virpax Pharmaceuticals investors about its performance. Virpax Pharmaceuticals is trading at 0.011 as of the 4th of January 2026; that is No Change since the beginning of the trading day. The stock's open price was 0.011. With this module, you can estimate the performance of a buy and hold strategy of Virpax Pharmaceuticals and determine expected loss or profit from investing in Virpax Pharmaceuticals over a given investment horizon. Check out Virpax Pharmaceuticals Correlation, Virpax Pharmaceuticals Volatility and Virpax Pharmaceuticals Alpha and Beta module to complement your research on Virpax Pharmaceuticals.
Please note, there is a significant difference between Virpax Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Virpax Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virpax Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Virpax Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Virpax Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Virpax Pharmaceuticals.
0.00
06/13/2024
No Change 0.00
0.0
In 1 year 6 months and 25 days
01/04/2026
0.00
If you would invest 0.00 in Virpax Pharmaceuticals on June 13, 2024 and sell it all today you would earn a total of 0.00 from holding Virpax Pharmaceuticals or generate 0.0% return on investment in Virpax Pharmaceuticals over 570 days. Virpax Pharmaceuticals is related to or competes with Sanofi ADR, Amgen, Merck, Boston Scientific, Novo Nordisk, and Danaher. Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and dru... More
Virpax Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Virpax Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Virpax Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Virpax Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Virpax Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Virpax Pharmaceuticals historical prices to predict the future Virpax Pharmaceuticals' volatility.
Virpax Pharmaceuticals is out of control given 3 months investment horizon. Virpax Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.16, which indicates the firm had a 0.16 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-four different technical indicators, which can help you to evaluate if expected returns of 21.14% are justified by taking the suggested risk. Use Virpax Pharmaceuticals Coefficient Of Variation of 718.27, risk adjusted performance of 0.1087, and Semi Deviation of 20.01 to evaluate company specific risk that cannot be diversified away. Virpax Pharmaceuticals holds a performance score of 12 on a scale of zero to a hundred. The entity has a beta of 20.58, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Virpax Pharmaceuticals will likely underperform. Use Virpax Pharmaceuticals value at risk and the relationship between the semi variance and day typical price , to analyze future returns on Virpax Pharmaceuticals.
Auto-correlation
0.31
Below average predictability
Virpax Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Virpax Pharmaceuticals time series from 13th of June 2024 to 25th of March 2025 and 25th of March 2025 to 4th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Virpax Pharmaceuticals price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Virpax Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
0.31
Spearman Rank Test
0.35
Residual Average
0.0
Price Variance
0.08
Virpax Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Virpax Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Virpax Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Virpax Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Virpax Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Virpax Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Virpax Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Virpax Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Virpax Pharmaceuticals pink sheet over time.
Current vs Lagged Prices
Timeline
Virpax Pharmaceuticals Lagged Returns
When evaluating Virpax Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Virpax Pharmaceuticals pink sheet have on its future price. Virpax Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Virpax Pharmaceuticals autocorrelation shows the relationship between Virpax Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Virpax Pharmaceuticals.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.